Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors - Concepedia

Concepedia

Publication | Closed Access

Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors

43

Citations

15

References

2018

Year

K. Saboundji, J.B. Auliac, Maurice Pérol, G François, Henri Janicot, M. Marcq, Catherine Dubos‐Arvis, Aldo Renault, Florian Guisier, L. Odier,

Targeted Oncology

Leptomeningeal MetastasesMedicineEgfr-tyrosine Kinase InhibitorsPharmacologyPathologyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung Cancer

References

	Year	Citations

Page 1

Page 1